New drug combo aims to outsmart pancreatic cancer before surgery
Disease control
Not yet recruiting
This early-phase study tests whether adding the experimental drug NP137 to standard chemotherapy can change how pancreatic cancer cells behave. About 25 people with resectable pancreatic cancer will receive NP137 before surgery and then again with chemotherapy after surgery. The …
Phase: PHASE1 • Sponsor: Aram Hezel • Aim: Disease control
Last updated May 26, 2026 12:04 UTC